Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles

US Stock Market Move | Bilibili, Inc. Sponsored ADR Class Z (BILI.US) rises more than 5%; daily video and podcast content viewing time breaks one billion minutes for the first time.

US Stock Market Move | Ford Motor Company (F.US) rose more than 8% as it enters the large-scale energy storage market with Contemporary Amperex Technology technology.

In the AI era, the technology industry continues to lay off employees. Microsoft Corporation's (MSFT.US) subsidiary LinkedIn has initiated a new round of personnel adjustments.
US Stock Market Move | Bilibili, Inc. Sponsored ADR Class Z (BILI.US) rises more than 5%; daily video and podcast content viewing time breaks one billion minutes for the first time.

US Stock Market Move | Ford Motor Company (F.US) rose more than 8% as it enters the large-scale energy storage market with Contemporary Amperex Technology technology.

In the AI era, the technology industry continues to lay off employees. Microsoft Corporation's (MSFT.US) subsidiary LinkedIn has initiated a new round of personnel adjustments.

RECOMMEND

Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026

HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026

The Chip Stock Frenzy Is Still Accelerating
11/05/2026


